Market Research Report
Heart Attack Diagnostics Market with COVID-19 Impact Analysis, By Test Type, By End User, and By Region - Size, Share, & Forecast from 2021-2027
|Heart Attack Diagnostics Market with COVID-19 Impact Analysis, By Test Type, By End User, and By Region - Size, Share, & Forecast from 2021-2027|
Published: February 1, 2021
AnalystView Market Insights
Content info: 290 Pages
Delivery time: 2-3 business days
The global heart attack diagnostics market was valued at USD 9.24 billion by 2019, growing with 8.4% CAGR during the forecast period, 2021-2027.
Heart attack diagnosis is related to the medical aid of patients battling with grave conditions, which needs subtle invasive observance devices and life support systems.
The increasing prevalence of diabetes and hypertension coupled with the adoption of an unhealthy lifestyle is likely to propel the heart attack diagnosis market growth to great extent. For instance, as per the Centers for Disease Control and Prevention (CDC)'s National Diabetes Statistics Report, 2020, more than 10.5% of the US population (i.e. 34 million population) have diabetes. Whereas, around 7.3 million people were suffering from diabetes, but have not yet been diagnosed.
Besides, the increasing aged population, as well as increasing obesity concern among the population, contribute to the significant growth for the market during the forecast period. For instance, according to the World Health Organization (WHO), in 2019, more than 38.0 million children (under the age of 5 years) were overweight. Once considered a high-income country problem, obesity and overweight are also on the rise in low- and middle-income regions, particularly in urban settings. For instance, in African countries, the number of overweight population increased by 24% since 2000. Such an increasing number of obese population will stimulate the incidences of cardiovascular problems, driving the heart attack diagnosis market growth.
In terms of test type, the troponin blood test segment dominated in heart attack diagnostic and is expected to continue its dominance during the review period. This is attributed due to the rapid, accurate results, with a short period.
Regionally, North America expected to dominate the market in the global heart attack diagnostics market during the forecast period. This is attributed due to the increasing prevalence of the diabetic population coupled with increasing obesity is one of the major factors to contribute significant growth of the heart attack the diagnostic market in the region.
Furthermore, Asia-Pacific is estimated to be the fastest-growing region during the forecast period due to oversized population as well as increasing incidence of chronic disease in certain regions that propel the growth of the heart attack diagnostic market in the region. For instance, According to revealed reports, Asian country leads the Asia Pacific section as a result of the high incidence of heart attacks and soaring death rates because of heart diseases.
Strategic mergers and acquisitions or product launches are some of the key strategies adopted by key players to remain competitive. Recently, in June 2020, Novo Nordisk, under its strategy to expand the company's cardiovascular product offering, bought AstraZeneca spin-off Corvidia Therapeutics. This strategic collaboration is aimed at Novo's ambition to diversify its offering and expand its footprint in core therapeutic areas of obesity and diabetes.
Key features of the study:
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL HEART ATTACK DIAGNOSTICS MARKET KEY PLAYERS
Siemens Healthcare GmbH
Koninklijke Philips N.V.
Bionet Co., Ltd.
Toshiba Medical Systems Corporation
F. Hoffmann-La Roche Ltd.
Hitachi Medical Systems
Bio-Rad Laboratories Inc.
Life Sign LLC
GLOBAL HEART ATTACK DIAGNOSTICS MARKET, BY TEST TYPE
Creatine Kinase MB Isoenzyme (CK-MB)
Positron-Emission Tomography (PET) Scanning
GLOBAL HEART ATTACK DIAGNOSTICS MARKET, BY END USER
Ambulatory Surgical Centres
GLOBAL HEART ATTACK DIAGNOSTICS MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of LATAM
The Middle East and Africa
United Arab Emirates
Rest of MEA
List of Tables
TABLE Global Heart Attack Diagnosticsmarket, by Test Type 2016-2027 (USD Million)
TABLE Global Heart Attack Diagnostics market, by End User 2016-2027 (USD Million)
List of Figures